Peak Bio, Inc. financial data

Symbol
PKBO, PKBOW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4900 Hopyard Road, Suite 100, Pleasanton, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Ignyte Acquisition Corp. (to 11/2/2022)
Latest financial report
Q3 2023 - Jun 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13 % -14.6%
Debt-to-equity -123 % -88.8%
Return On Equity 128 % -70%
Return On Assets -564 % -1540%
Operating Margin -3.09 K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.1 M shares +10.8%
Common Stock, Shares, Outstanding 22.6 M shares +1372%
Entity Public Float 56.7 M USD +2.16%
Common Stock, Value, Issued 2.26 K USD +1369%
Weighted Average Number of Shares Outstanding, Basic 21.6 M shares +26.1%
Weighted Average Number of Shares Outstanding, Diluted 36 M shares +110%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 554 K USD +44.8%
Research and Development Expense 2.12 M USD -36.3%
General and Administrative Expense 12 M USD +73.9%
Operating Income (Loss) -17.1 M USD -12%
Nonoperating Income (Expense) -1.95 M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.1 M USD
Income Tax Expense (Benefit) -30 K USD
Net Income (Loss) Attributable to Parent -19.1 M USD -26.9%
Earnings Per Share, Basic -0.98 USD/shares -11.4%
Earnings Per Share, Diluted -0.99 USD/shares -12.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 94.4 K USD -78.4%
Assets, Current 1.26 M USD +821%
Property, Plant and Equipment, Net 185 K USD
Operating Lease, Right-of-Use Asset 0 USD
Goodwill 0 USD
Other Assets, Noncurrent 5 K USD
Assets 1.51 M USD -97.4%
Accounts Payable, Current 5.68 M USD
Accrued Liabilities, Current 3.12 M USD +111%
Liabilities, Current 18.7 M USD +796%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD
Other Liabilities, Noncurrent 231 K USD
Liabilities 19.1 M USD +699%
Accumulated Other Comprehensive Income (Loss), Net of Tax 130 K USD
Retained Earnings (Accumulated Deficit) -37.6 M USD -1850%
Stockholders' Equity Attributable to Parent -17.6 M USD -222%
Liabilities and Equity 1.51 M USD -97.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.44 M USD -23.5%
Net Cash Provided by (Used in) Financing Activities 1.14 M USD -8.49%
Common Stock, Shares Authorized 60 M shares +20%
Common Stock, Shares, Issued 22.6 M shares +1372%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 154 K USD -77.1%
Deferred Tax Assets, Valuation Allowance 28.9 M USD +3.68%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 30 M USD +7.5%
Operating Lease, Liability 4.35 M USD
Depreciation 41.4 K USD +0.73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19 M USD
Lessee, Operating Lease, Liability, to be Paid 5.07 M USD
Property, Plant and Equipment, Gross 753 K USD
Operating Lease, Liability, Current 4.35 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.19 M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 723 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.26 M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares +900%
Lessee, Operating Lease, Liability, to be Paid, Year Four 422 K USD
Operating Lease, Payments 690 K USD -100%
Additional Paid in Capital 19.9 M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 28.9 M USD +3.81%
Share-based Payment Arrangement, Expense 503 K USD -51.6%
Interest Expense 2.32 M USD +197631%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%